(Total Views: 945)
Posted On: 08/23/2020 7:28:37 AM
Post# of 157281
I understand if people are concerned with the words Leronlimab coming out of Trump’s mouth. Could be the HQ touting or the worry that it becomes a political weapon and half the country doesn’t get on board. But the reality is that Trump touting HQ or Remdesivir wasn’t smart because neither have the real, definitive goods. There’s more nothing there than there is something. The majority of the people aren’t dumb. They see through it. You can argue HQ can be helpful early but there’s also a ton of mediocre-to-no evidence from studies out there. Same with Remdesivir.
Leronlimab is different. It has the goods.
Trump can talk about the tremendous success of EIND patients, get into some personal stories that have hit the news like Samantha Mottet (sp?), and he can also talk about the huge reduction in objective risk of the NEWS2 score. Which, by the way, contains objects to be measured that the public would understand like blood pressure, oxygen saturation, loss of consciousness, etc. Things we all know from the news to be worrisome as potential Covid symptoms.
Or even if he doesn’t talk about those things the subsequent news deep diving into Cytodyn would uncover how legit it really is.
I think the evidence behind Leronlimab is enough to get any rational human being excited about the things that are important to them. Returning to work, being around friends again, NOT DYING, etc. Nobody is going to turn down a real chance at normalcy just because Trump was the first one to make them aware of it.
That being said, and with full disclosure that I’m only invested in Cytodyn (completely all in), I just don’t trust that it’s going to be us later today. I truly hope it is because we need the exposure and the world needs Leronlimab. I believe we’ll hear one of four things:
1. He’s dropping some sort of executive order that the FDA approves plasma. He believes in it (he’s on record saying positive things) and this would be something right up the alley he has spent a lot of time in.
2. A major study like Solidarity has some sort of preliminary or interim result
3. He’s going to use the latest Rem outcomes to announce it’s fully approved.
Last but not least...
4. Somehow it’s about Leronlimab and I can finally stop obsessing over and refreshing the content at four different message boards all day every day.
Leronlimab is different. It has the goods.
Trump can talk about the tremendous success of EIND patients, get into some personal stories that have hit the news like Samantha Mottet (sp?), and he can also talk about the huge reduction in objective risk of the NEWS2 score. Which, by the way, contains objects to be measured that the public would understand like blood pressure, oxygen saturation, loss of consciousness, etc. Things we all know from the news to be worrisome as potential Covid symptoms.
Or even if he doesn’t talk about those things the subsequent news deep diving into Cytodyn would uncover how legit it really is.
I think the evidence behind Leronlimab is enough to get any rational human being excited about the things that are important to them. Returning to work, being around friends again, NOT DYING, etc. Nobody is going to turn down a real chance at normalcy just because Trump was the first one to make them aware of it.
That being said, and with full disclosure that I’m only invested in Cytodyn (completely all in), I just don’t trust that it’s going to be us later today. I truly hope it is because we need the exposure and the world needs Leronlimab. I believe we’ll hear one of four things:
1. He’s dropping some sort of executive order that the FDA approves plasma. He believes in it (he’s on record saying positive things) and this would be something right up the alley he has spent a lot of time in.
2. A major study like Solidarity has some sort of preliminary or interim result
3. He’s going to use the latest Rem outcomes to announce it’s fully approved.
Last but not least...
4. Somehow it’s about Leronlimab and I can finally stop obsessing over and refreshing the content at four different message boards all day every day.
(3)
(0)
